thalidomide has been researched along with isoniazid in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (52.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 2 (8.00) | 29.6817 |
| 2010's | 9 (36.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Akgün, H; Berk, B; Karamelekoğlu, I; Kocagöz, T; Kurnaz, I; Oktem, S; Sarıbıyık, G | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bera, S; Mondal, D | 1 |
| Sobue, I | 1 |
| Mumenthaler, M | 1 |
| Thomas, PK | 1 |
| Contreras Duenas, F | 1 |
| Johansson, B | 1 |
| Bischoff, A | 1 |
| Cavanagh, JB | 1 |
| Gibbels, E | 1 |
| Suchenwirth, R | 1 |
| Marcus, JC | 1 |
| Freedman, VH; Kaplan, G; Sokol, K; Tsenova, L | 1 |
| MOYA, F; THORNDIKE, V | 1 |
| MOTULSKY, AG | 1 |
| JOERGENSEN, G | 1 |
| Ehrt, S; Fallows, D; Kaplan, G; Koo, MS; Manca, C; Muller, G; O'Brien, P; Subbian, S; Sung, N; Tsenova, L; Yang, G | 1 |
| Fallows, D; Kaplan, G; Koo, MS; Muller, G; O'Brien, P; Peixoto, B; Subbian, S; Tsenova, L; Yang, G; Zeldis, JB | 1 |
| Dartois, V; Fallows, D; Kaplan, G; Koo, MS; Muller, G; O'Brien, P; Peixoto, B; Subbian, S; Tsenova, L; Yang, G | 1 |
| Bode, HR; Brooun, M; Manoukian, A; McNeill, H; Shimizu, H | 1 |
8 review(s) available for thalidomide and isoniazid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
[Exogenous toxic neuropathy (author's transl)].
Topics: Acrylamides; Adolescent; Adult; Aged; Aldrin; Carbon Disulfide; Chloramphenicol; Clioquinol; DDT; Disulfiram; Endrin; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Nervous System Diseases; Phenytoin; Sulfonamides; Thalidomide; Thiamphenicol; Trichloroethylene; Vincristine | 1976 |
The morphological basis for alterations in nerve conduction in peripheral neuropathy.
Topics: Amyloidosis; Animals; Axons; Beriberi; Cresols; Demyelinating Diseases; Diabetic Neuropathies; Diffuse Cerebral Sclerosis of Schilder; Diphtheria; Humans; Isoniazid; Lead Poisoning; Microscopy, Electron; Myelin Sheath; Nerve Degeneration; Nerve Regeneration; Neural Conduction; Neuritis; Peripheral Nervous System Diseases; Phosphates; Polyradiculopathy; Ranvier's Nodes; Refsum Disease; Schwann Cells; Thalidomide | 1971 |
[Side effects of drugs. 4. Drug induced polyneuropathies and myopathies].
Topics: Adrenocorticotropic Hormone; Chloroquine; Glucocorticoids; Humans; Hydralazine; Isoniazid; Muscular Diseases; Neurons, Afferent; Nitrofurans; Peripheral Nervous System Diseases; Thalidomide; Vincristine | 1969 |
Peripheral neuropathy caused by chemical agents.
Topics: Acrylamides; Animals; Arsenic; Axons; Carbon Disulfide; Disulfiram; Humans; In Vitro Techniques; Isoniazid; Lead Poisoning; Mercury Poisoning; Myelin Sheath; Neurons; Nitrofurans; Organophosphorus Compounds; Peripheral Nervous System Diseases; Porphyrias; Pyridoxine; Thalidomide; Thallium; Thiamine; Thiocarbamates; Vinca Alkaloids | 1973 |
PHARMACOGENETICS.
Topics: Abnormalities, Drug-Induced; Animals; Dicumarol; Dogs; Drug Hypersensitivity; Drug Tolerance; Ethnology; Genetics; Genetics, Medical; Glucosephosphate Dehydrogenase Deficiency; Glucosephosphates; Guinea Pigs; Hemoglobins; Hemoglobins, Abnormal; Humans; Isoniazid; Metabolism; Mice; Mutation; Pharmacogenetics; Pharmacology; Rabbits; Rats; Research; Succinylcholine; Thalidomide; Toxicology | 1964 |
[PHARMACOGENETICS].
Topics: Abnormalities, Drug-Induced; Atropine; Cleft Palate; Cortisone; Genetics; Glucosephosphate Dehydrogenase Deficiency; Glucosephosphates; Isoniazid; Mutation; Oxidoreductases; Pharmaceutical Preparations; Pharmacogenetics; Pharmacology; Primaquine; Thalidomide; Toxicology | 1964 |
17 other study(ies) available for thalidomide and isoniazid
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Synthesis and antimycobacterial activity of some phthalimide derivatives.
Topics: Animals; Antitubercular Agents; Cell Line; Cell Survival; Drug Resistance, Multiple, Bacterial; Isoniazid; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phthalimides; Pyrazinamide | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
[Exotoxin-induced polyneuropathies].
Topics: Acrylamides; Carbon Tetrachloride Poisoning; DDT; Disulfiram; Ethanol; Humans; Hydralazine; Isoniazid; Lead Poisoning; Meprobamate; Mercury Poisoning; Methaqualone; Oxyquinoline; Polyneuropathies; Sulfur Dioxide; Thalidomide; Thallium | 1975 |
[Early diagnosis, therapy, and research in the control of leprosy].
Topics: Aniline Compounds; Drug Synergism; Europe; Humans; Hyperbaric Oxygenation; Isoniazid; Leprosy; Phenazines; Sulfones; Thalidomide; Time Factors; Tropical Climate; United States; Vitamin B 12; Vitamin B Complex | 1970 |
[Drug-induced polyneuropathy].
Topics: Abnormalities, Drug-Induced; Adult; Animals; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Iatrogenic Disease; Infant, Newborn; Isoniazid; Male; Nitrofurantoin; Peripheral Nervous System Diseases; Pregnancy; Thalidomide | 1970 |
[Differential diagnosis of polyneuritides].
Topics: Arsenic Poisoning; Carbon Disulfide; Diabetic Neuropathies; Diagnosis, Differential; Diphtheria; Humans; Isoniazid; Myositis; Nitrofurantoin; Polyneuropathies; Quadriplegia; Reflex; Terminology as Topic; Thalidomide | 1969 |
[Polyneuritis (polyneuropathy) of drug origin].
Topics: Anticonvulsants; Humans; Isoniazid; Nitrofurantoin; Polyneuropathies; Thalidomide | 1968 |
Non-teratogenicity of antituberculous drugs.
Topics: Abnormalities, Drug-Induced; Aminosalicylic Acids; Antitubercular Agents; Drug Synergism; Ethionamide; Female; Humans; Infant; Infant, Newborn; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Streptomycin; Thalidomide; Tuberculosis, Pulmonary | 1967 |
A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death.
Topics: Animals; Antibiotics, Antitubercular; Disease Models, Animal; Drug Therapy, Combination; Immunosuppressive Agents; Isoniazid; Mycobacterium bovis; Rabbits; Rifampin; Thalidomide; Tuberculosis, Meningeal | 1998 |
Passage of drugs across the placenta.
Topics: Anesthetics; Anti-Bacterial Agents; Atropa belladonna; Barbiturates; Female; Humans; Hypnotics and Sedatives; Isoniazid; Maternal-Fetal Exchange; Muscle Relaxants, Central; Narcotic Antagonists; Narcotics; Placenta; Pregnancy; Sulfonamides; Thalidomide; Tranquilizing Agents | 1962 |
Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice.
Topics: Animals; Antibiotics, Antitubercular; Bacterial Load; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Down-Regulation; Drug Evaluation, Preclinical; Drug Interactions; Immunity, Innate; Isoniazid; Lung; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Mycobacterium tuberculosis; Phosphodiesterase 4 Inhibitors; Thalidomide; Tuberculosis | 2011 |
Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology.
Topics: Animals; Antitubercular Agents; Blotting, Western; Colony-Forming Units Assay; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Drug Synergism; Drug Therapy, Combination; Female; Isoniazid; Lung; Macrophage Activation; Male; Matrix Metalloproteinases; Mycobacterium tuberculosis; Phosphodiesterase 4 Inhibitors; Pulmonary Fibrosis; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thalidomide; Tuberculosis, Pulmonary | 2011 |
Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs.
Topics: Animals; Antitubercular Agents; Bacterial Load; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Resistance, Bacterial; Female; Gene Expression Regulation; Isoniazid; Lung; Macrophages; Male; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Phosphodiesterase 4 Inhibitors; Rabbits; Thalidomide; Tuberculosis; Tumor Necrosis Factor-alpha | 2011 |
Organizer formation in Hydra is disrupted by thalidomide treatment.
Topics: Animals; beta Catenin; Body Patterning; Casein Kinase I; Gene Expression Regulation, Developmental; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Green Fluorescent Proteins; Hydra; In Situ Hybridization; Organizers, Embryonic; Signal Transduction; Teratogens; Thalidomide; Transcription Factors; Wnt Proteins | 2013 |